Stock screenerAll disclosures →
EDGAR →
RNXT
Conviction 55HealthcareScan · Mon, Aug 10, 2026RNXT$1.14+1.79%
ResistanceSupportVol 14Insider buyVol MA14 323.47K
May 11May 28Jun 16Jul 6Jul 23Aug 10
Price1.14
Change+1.79%
Gap+0.00%
Rel volume0.73×
Avg volume275.55K
Avg $ vol274.98K
SMA 200.9511
SMA 500.9286
SMA 2000.9393
Price vs 50+22.77%
Price vs 200+21.36%
MA stackmixed
50/200 cross—
Supertrendup · 0.9326
RSI (14)69
MACD hist0.03
MACD cross—
Stoch %K / %D83 / 84
ADX (14)39
+DI / −DI34 / 5
RSI divergence—
MACD divergence—
ATR %+5.78%
ADR %6.52%
52w high1.34
52w low0.7325
From 52w high-14.93%
Above 52w low+55.63%
New 52w highNo
SqueezeOff
Bollinger width42.93%
%B0.96
Donchian pos83.78%
Donchian high1.20
Donchian low0.8300
AVWAP (52w high)1.03
vs AVWAP high+10.35%
AVWAP (52w low)0.9490
vs AVWAP low+20.13%
OBV trendUp
Chaikin MF (20)0.17
Today vs 20d0.73×
Avg vol (14d)323.47K
Avg vol (20d)275.55K
Avg $ vol (20d)274.98K
Market cap51.41M
RS 3m (vs SPY)+21.56%
RS 6m (vs SPY)+3.67%
RS line new highNo
Trend template6/8
Technical rank87.4
1 week+7.55%
1 month+22.57%
3 months+32.01%
6 months+15.15%
1 year-5.00%
YTD+36.49%
P/E-4.60
P/B4.56
P/S45.78
P/FCF-4.68
EPS-0.3200
Div yield—
ROE-99.14%
ROA-79.98%
Debt/Eq—
Current7.15
EV/EBITDA-3.72
Gross margin70.88%
Net margin-994.48%
Rev growth2511.63%
EPS growth-26.71%
Price target—
Target upside—
Analyst rating—
Institutional—
Ent. value39.05M
Revenue563K
Net income-3.52M
Gross profit479K
Free cash flow-10.97M
IndustryPHARMACEUTICAL PREPARATIONS
ExchangeNasdaq
Shares out45.1M
Employees17
ListedThu, Aug 26, 2021
Free float38.91M
Float %86.4%
Short interest327.87K
Days to cover1.7d
Short volume45.2%
Squeeze score14 / 100
Next earningsWed, Aug 12, 2026 · after (2d)
EPS forecast−$0.08 · 2 est
Last EPS vs est—
Last surprise—
Setup gradeC
Conviction55 / 100
Pattern quality—
Tech rank87.4 / 100
Group rank86 / 100 · Leading
Status laneNo active setup
Setup direction—
Pattern family
Resistance1.05
Support0.8350
Days since event—
Candle confirm—
News sentiment—
Financials as of Tue, Mar 31, 2026 · quarterly.
Congress activity
Disclosed STOCK Act trades in RNXT
No recent disclosed trades by Congress in RNXT. STOCK Act filings can lag the trade by up to 45 days.
Insider activity
SEC Form 4 transactions in RNXT · 1 buy
| Insider | Side | Shares | Value | Traded | Filed |
|---|---|---|---|---|---|
VOLL MARK Chief Financial Officer · Common Stock · 2026-05-19 | Other | — | — | 2026-05-19 | 2026-05-21 |
VOLL MARK Chief Financial Officer · Common Stock · 2026-05-19 | Buy | 25K | $20K | 2026-05-19 | 2026-05-21 |
SEC filings
EDGAR filings in RNXT · 3 recent
Get daily signals & real-time alerts.
StockSetups scans ~12,300 US stocks & ETFs after every close and sorts every long setup into four ranked lanes — each with a trade plan — plus an always-on engine firing 35+ real-time intraday alerts. Free for 14 days, cancel in one click.
Start free — 14-day full access →Educational data, not financial advice. Patterns, levels and the trade plan are algorithmic, not a recommendation to trade.